Breast Milk and Saliva Lactoferrin Levels and Postnatal Cytomegalovirus Infection

2020 ◽  
Author(s):  
Kristin E. D. Weimer ◽  
Hunter Roark ◽  
Kimberley Fisher ◽  
C. Michael Cotten ◽  
David A. Kaufman ◽  
...  
Keyword(s):  
Breast Milk ◽  
Very Low Birth Weight ◽  
Quantitative Polymerase Chain Reaction ◽  
Neutralization Assay ◽  
Enzyme Linked Immunosorbent Assay ◽  
Lactating Mothers ◽  
Life Threatening ◽  
Polymerase Chain

Abstract Objective Very low birth weight preterm infants are at risk for life-threatening infections in the NICU. Breast milk protects against infections but carries the risk of infection by cytomegalovirus (CMV) shed in mother's milk. Lactoferrin is a breast milk and saliva protein with potent neutralizing activity against CMV. Study Design VLBW, maternal breast milk fed infants in the NICU and their lactating mothers were enrolled and followed for 3 months/discharge. Breast milk and infant saliva samples were collected biweekly. Maternal CMV status was determined on breast milk. CMV was measured using quantitative polymerase chain reaction and lactoferrin by enzyme-linked immunosorbent assay. Results In an in vitro neutralization assay, the IC90 of purified human lactoferrin against CMV was 2.08 ng/mL. Bovine lactoferrins were more potent, IC90s > 10-fold higher. Lactoferrin was detected in all breast milk (median: 3.3 × 106 ng/mL) and saliva (median: 84.4 ng/swab) samples. Median CMV load in breast milk was 893 copies/mL. There was no correlation between breast milk lactoferrin concentration and CMV load. Five infants acquired postnatal CMV. There was no difference in saliva or breast milk lactoferrin concentration for mother–infant pairs and postnatal CMV acquisition. Conclusion Lactoferrin neutralizes CMV in vitro, but concentrations in breast milk and saliva are likely too low for effective neutralization in vivo.

scholarly journals Paeonol attenuates inflammation by targeting HMGB1 through upregulating miR-339-5p

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Liyan Mei ◽  
Meihong He ◽  
Chaoying Zhang ◽  
Jifei Miao ◽  
Quan Wen ◽  
...  
Keyword(s):  
Quantitative Polymerase Chain Reaction ◽  
Chinese Herb ◽  
Cecal Ligation ◽  
Underlying Mechanism ◽  
Raw264.7 Cells ◽  
Enzyme Linked Immunosorbent Assay ◽  
Life Threatening ◽  
Moutan Cortex ◽  
Anti Inflammatory

AbstractSepsis is a life-threatening disease caused by infection. Inflammation is a key pathogenic process in sepsis. Paeonol, an active ingredient in moutan cortex (a Chinese herb), has many pharmacological activities, such as anti-inflammatory and antitumour actions. Previous studies have indicated that paeonol inhibits the expression of HMGB1 and the transcriptional activity of NF-κB. However, its underlying mechanism is still unknown. In this study, microarray assay and reverse transcription-quantitative polymerase chain reaction (RT-qPCR) results confirmed that paeonol could significantly up-regulate the expression of miR-339-5p in RAW264.7 cells stimulated by LPS. Dual-luciferase assays indicated that miR-339-5p interacted with the 3′ untranslated region (3′-UTR) of HMGB1. Western blot, immunofluorescence and enzyme-linked immunosorbent assay (ELISA) analyses indicated that miR-339-5p mimic and siHMGB1 both negatively regulated the expression and secretion of inflammatory cytokines (e.g., HMGB1, IL-1β and TNF-α) in LPS-induced RAW264.7 cells. Studies have confirmed that IKK-β is targeted by miR-339-5p, and we further found that paeonol could inhibit IKK-β expression. Positive mutual feedback between HMGB1 and IKK-β was observed when we silenced HMGB1 or IKK-β. These results indicated that paeonol could attenuate the inflammation mediated by HMGB1 and IKK-β by upregulating miR-339-5p expression. In addition, we constructed CLP model mice by cecal ligation and puncture. Paeonol was used to intervene to investigate its anti-inflammatory effect in vivo. The results showed that paeonol could improve the survival rate of sepsis mice and protect the kidney of sepsis mice.

scholarly journals L-Theanine Reduced the Development of Knee Osteoarthritis in Rats via Its Anti-Inflammation and Anti-Matrix Degradation Actions: In Vivo and In Vitro Study

Nutrients ◽  
2020 ◽  
Vol 12 (7) ◽  
pp. 1988 ◽  
Author(s):  
Hui Bai ◽  
Zhiheng Zhang ◽  
Yue Li ◽  
Xiaopeng Song ◽  
Tianwen Ma ◽  
...  
Keyword(s):  
Nitric Oxide ◽  
Inflammatory Cytokines ◽  
Inflammatory Responses ◽  
Quantitative Polymerase Chain Reaction ◽  
Hydrolytic Enzyme ◽  
Enzyme Linked Immunosorbent Assay ◽  
Matrix Degradation ◽  
In Vivo Animal Model

The etiology of osteoarthritis (OA) is multifactorial, with no effective disease-modifying-drugs. L-theanine has been reported to inhibit inflammatory responses in some diseases and this study aimed to investigate the effect of L-theanine on Interleukin-1(IL-1)β-stimulated chondrocytes, and in an injury-induced OA rat model. Primary chondrocytes were stimulated by IL-1β (10 ng/mL) for 24 h and then co-cultured with L-theanine for 24 h. The effects of L-theanine on IL-1β-stimulated expression of pro-inflammatory cytokines and hydrolytic enzyme were analyzed using Western blotting, quantitative polymerase chain reaction (q-PCR) and enzyme-linked immunosorbent assay (ELISA) kits. An immunofluorescence assay was used to detect nuclear factor kappa B (NF-κB) phosphorylation. OA was induced by anterior cruciate ligament transection (ACLT) surgery in rats and celecoxib was used as a positive control. OA severity was measured using the Osteoarthritis Research Society International (OARSI) grading system to describe histological changes. The results showed that L-theanine decreased the expression of pro-inflammatory mediators, including cyclooxygenase-2 (COX-2), prostaglandin E2 (PGE-2), inducible nitric oxide synthase (iNOS), and nitric oxide (NO), both in vivo and in vitro. L-theanine treatment inhibited IL-1β-induced upregulation of matrix metalloproteinases (MMP)-3 and MMP-13, as well as inhibited NF-κB p65 activation. In vivo animal model showed that L-theanine administration (200 mg/kg) significantly alleviated OA lesions and decreased OARSI score. Our data indicated that L-theanine decreased inflammatory cytokines and protected extracellular matrix degradation through inhibition of the NF-κB pathway, and L-theanine may be considered a promising therapeutic strategy in OA prevention.

scholarly journals A Tobacco-Derived Thymosinβ4 Concatemer Promotes Cell Proliferation and Wound Healing in Mice

2016 ◽  
Vol 2016 ◽  
pp. 1-8 ◽  
Author(s):  
Rylosona Janarthini ◽  
Xiaolei Wang ◽  
Lulu Chen ◽  
Lei Gao ◽  
Lingxia Zhao
Keyword(s):  
Wound Healing ◽  
Quantitative Polymerase Chain Reaction ◽  
Great Promise ◽  
Enzyme Linked Immunosorbent Assay ◽  
Migration Assay ◽  
Direct Administration ◽  
Polymerase Chain ◽  
Endothelial Migration ◽  
Unit Repeat

Thymosinβ4 (Tβ4) is a peptide that is known to play important roles in protection, regeneration, and remodeling of injured tissues in humans, and that shows great promise in a range of clinical applications. However, current strategies to Tβ4 are insufficient to meet growing demand and have a number of limitations. In this current study we investigated whether expression of recombinant Tβ4 in plants, specifically in tobacco (Nicotiana tabacum) leaves, represents an effective approach. To address this question, a 168 bpTβ4gene optimized for tobacco codon usage bias was constitutively expressed in tobacco as a 4-unit repeat concatemer, fused to a polyhistidine tag. Quantitative polymerase chain reaction and Western blot analyses were used to verify4×Tβ4expression in 14 transgenic tobacco lines and enzyme-linked immunosorbent assay analysis indicated 4×Tβ4 protein concentrations as high as 3 μg/g of fresh weight in the leaves. We observed that direct administration of tobacco-derived Tβ4 was more effective than Tβ4 either obtained commercially or derived from expression inEscherichia coliat promoting splenocyte proliferationin vitroand wound healing in mice through an endothelial migration assay. This study provides new insights into the development of plant-derived therapeutic proteins and their application by direct administration.

214 USE OF VIRUS ISOLATION AND QUANTITATIVE POLYMERASE CHAIN-REACTION TECHNIQUES TO DETECT BOVINE VIRAL DIARRHEA VIRUS (BVDV) IN SINGLE OR SMALL GROUPS OF PRE-IMPLANTATION BOVINE EMBRYOS

2006 ◽  
Vol 18 (2) ◽  
pp. 214
Author(s):  
J. Waldrop ◽  
M. Givens ◽  
K. Riddell ◽  
P. Galik ◽  
D. Stringfellow
Keyword(s):  
Small Groups ◽  
Virus Isolation ◽  
Quantitative Polymerase Chain Reaction ◽  
Bovine Embryos ◽  
Chain Reaction ◽  
Diarrhea Virus ◽  
Polymerase Chain ◽  
Viral Diarrhea Virus

Because of its broad distribution among populations of cattle and its association with materials of animal origin used in embryo production, bovine viral diarrhea virus (BVDV) is a potential problem in applications of embryo technologies. While some isolates of BVDV are known to associate with both in vivo-derived and in vitro-produced bovine embryos, it has yet to be determined if the quantity of virus associated with exposed zona pellucida-intact embryos is sufficient to infect susceptible recipient cows via the intrauterine route. Techniques to detect and quantify BVDV associated with single transferable embryos are important to determine the risk of transmitting BVDV via embryo transfer. The objectives of this study were to define reproducible techniques to detect and quantify BVDV associated with single or small groups of bovine embryos contained in small aliquots of medium using virus isolation (VI) or real time quantitative polymerase chain reaction (Q-PCR) assays. In vivo-derived and in vitro-produced embryos were exposed for 2 h to approximately 106-cell culture infective doses (50% endpoint) per mililiter of a high affinity strain of BVDV, SD-1, and then washed according to IETS guidelines. Embryos were assayed in groups of five or two embryos, or single. There were 5 replicates of the group of five embryos, 4 of the group of two embryos, and 3 of the single embryos for the in vivo-derived embryos undergoing VI; 5, 4, and 2 replicates, respectively, undergoing Q-PCR, and 2, 5, and 2 replicates, respectively, for the in vitro-produced embryo groups undergoing VI and Q-PCR. Those to be assayed by VI were sonicated and the sonicate fluids were layered onto Madin Darby Bovine Kidney (MDBK) cells and passaged to allow for viral replication; an immunoperoxidase monolayer assay was then used for viral detection. A Roche� RNA/DNA extraction kit (Roche Diagnostic Systems, Inc., Somerville, NJ, USA) was used to extract RNA from virally exposed embryos, and extracted samples were assayed in duplicate Q-PCR reactions consisting of 100 �L. The primers used were L1 and U3 which are specific for conserved areas of the 5 prime nontranslated regions of the viral genome of BVDV. The PCR product was detected using hybridization probes s1 and s2 as in Struder et al. 2002 Biologicals 40, 289-296. In vivo-derived groups of five or two embryos, or single embryos, were positive for BVDV 100, 50, and 30% of the time, respectively, when VI was used and 100, 75 and 100%, respectively, when Q-PCR was used. The virus was detected in all of the in vitro-produced embryo groups of five, or two embryos, or single embryos, 100% of the time using VI, and in 100, 80, and 100% respectively, using Q-PCR. The virus isolation technique is highly sensitive but the need to destroy embryos by sonication to identify any embryo-associated virus precludes its use for embryos intended for transfer. Techniques for Q-PCR were sufficiently sensitive to detect and quantify 10 copies of RNA in a sample and to detect BVDV associated with single embryos.

scholarly journals In Vivo Association of Ku with Mammalian Origins of DNA Replication

2001 ◽  
Vol 12 (11) ◽  
pp. 3386-3401 ◽  
Author(s):  
Olivia Novac ◽  
Diamanto Matheos ◽  
Felipe D. Araujo ◽  
Gerald B. Price ◽  
Maria Zannis-Hadjopoulos
Keyword(s):  
Dna Replication ◽  
Quantitative Polymerase Chain Reaction ◽  
Polymerase Chain Reaction Analysis ◽  
Origin Firing ◽  
Origin Binding Protein ◽  
M Phase ◽  
Polymerase Chain ◽  
In Cells

Ku is a heterodimeric (Ku70/86-kDa) nuclear protein with known functions in DNA repair, V(D)J recombination, and DNA replication. Here, the in vivo association of Ku with mammalian origins of DNA replication was analyzed by studying its association withors8 and ors12, as assayed by formaldehyde cross-linking, followed by immunoprecipitation and quantitative polymerase chain reaction analysis. The association of Ku with ors8 and ors12 was also analyzed as a function of the cell cycle. This association was found to be approximately fivefold higher in cells synchronized at the G1/S border, in comparison with cells at G0, and it decreased by approximately twofold upon entry of the cells into S phase, and to near background levels in cells at G2/M phase. In addition, in vitro DNA replication experiments were performed with the use of extracts from Ku80+/+ and Ku80−/− mouse embryonic fibroblasts. A decrease of ∼70% in in vitro DNA replication was observed when the Ku80−/− extracts were used, compared with the Ku80+/+ extracts. The results indicate a novel function for Ku as an origin binding-protein, which acts at the initiation step of DNA replication and dissociates after origin firing.

The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera

Blood ◽  
2007 ◽  
Vol 110 (3) ◽  
pp. 1013-1021 ◽  
Author(s):  
Sabrina Dupont ◽  
Aline Massé ◽  
Chloé James ◽  
Irène Teyssandier ◽  
Yann Lécluse ◽  
...  
Keyword(s):  
Polycythemia Vera ◽  
Quantitative Polymerase Chain Reaction ◽  
Selective Advantage ◽  
Erythroid Progenitors ◽  
Molecular Events ◽  
Polymerase Chain ◽  
Late Stages ◽  
Early Phases

Abstract The JAK2 617V>F mutation is frequent in polycythemia vera (PV) and essential thrombocythemia (ET). Using quantitative polymerase chain reaction (PCR), we found that high levels of JAK2 617V>F in PV correlate with increased granulocytes and high levels of hemoglobin and endogenous erythroid colony formation. We detected normal progenitors and those that were heterozygous or homozygous for the mutation by genotyping ET and PV clonal immature and committed progenitors. In PV patients, we distinguished homozygous profiles with normal, heterozygous, and homozygous progenitors from heterozygous profiles with only heterozygous and normal progenitors. PV patients with a heterozygous profile had more mutated, committed progenitors than did other PV and ET patients, suggesting a selective amplification of mutated cells in the early phases of hematopoiesis. We demonstrated that mutated erythroid progenitors were more sensitive to erythropoietin than normal progenitors, and that most homozygous erythroid progenitors were erythropoietin independent. Moreover, we observed a greater in vitro erythroid amplification and a selective advantage in vivo for mutated cells in late stages of hematopoiesis. These results suggest that, for PV, erythrocytosis can occur through two mechanisms: terminal erythroid amplification triggered by JAK2 617V>F homozygosity, and a 2-step process including the upstream amplification of heterozygous cells that may involve additional molecular events.

scholarly journals Emodin Attenuates LPS-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome-Dependent Pyroptosis Signaling Pathway In vitro and In vivo

Inflammation ◽  
2021 ◽  
Author(s):  
Yuhan Liu ◽  
Luorui Shang ◽  
Jiabin Zhou ◽  
Guangtao Pan ◽  
Fangyuan Zhou ◽  
...  
Keyword(s):  
Acute Lung Injury ◽  
Lung Injury ◽  
Signaling Pathway ◽  
Nlrp3 Inflammasome ◽  
Quantitative Polymerase Chain Reaction ◽  
Interleukin 1 ◽  
Enzyme Linked Immunosorbent Assay ◽  
Protective Effects

Abstract—Emodin, the effective component of the traditional Chinese medicine Dahuang, has anti-inflammatory effects. However, the protective effects and potential mechanisms of emodin are not clear. This study investigated the protective effects and potential mechanisms of emodin on lipopolysaccharide (LPS)-induced acute lung injury (ALI) in vitro and in vivo. In vivo, we designed an LPS-induced ALI rat model. In vitro, we chose the J774A.1 cell line to establish an inflammatory cellular model, and knocked down NOD-like receptor family pyrin domain containing 3 (NLRP3) using small interfering RNA. The mRNA and protein expression of NLRP3, a C-terminal caspase recruitment domain (ASC), caspase 1 (CASP1), and gasdermin D (GSDMD) in cells and lung tissues were detected by western blot and real-time quantitative polymerase chain reaction (PCR). The expression levels of interleukin 1 beta (IL-1β) and IL-18 in the serum and supernatant were determined by the enzyme-linked immunosorbent assay. The degree of pathological injury in lung tissue was evaluated by hematoxylin and eosin (H&E) staining. In vitro, we demonstrated that emodin could inhibit NLRP3 and then inhibit the expression of ASC, CASP1, GSDMD, IL-1β, and IL-18. In vivo, we confirmed that emodin had protective effects on LPS-induced ALI and inhibitory effects on NLRP3 inflammasome -dependent pyroptosis. Emodin showed excellent protective effects against LPS-induced ALI by regulating the NLRP3 inflammasome-dependent pyroptosis signaling pathway.

scholarly journals Μελέτη παραγόντων της αγγειακής επασβέστωσης σε ασθενείς με διαβητική νεφροπάθεια

2019 ◽  
Author(s):  
Στέφανος Ρουμελιώτης
Keyword(s):  
Fragment Length Polymorphism ◽  
Matrix Gla Protein ◽  
Enzyme Linked Immunosorbent Assay ◽  
Nucleotide Polymorphisms ◽  
Single Nucleotide ◽  
Pcr Rflp ◽  
Epoxide Reductase ◽  
Polymerase Chain

Η Χρόνια Νεφρική Νόσος (ΧΝΝ) αποτελεί ένα σημαντικό επιδημιολογικό πρόβλημα, με αυξανόμενη συχνότητα και επιπολασμό και υψηλό κόστος στα εθνικά συστήματα υγείας, παγκοσμίως. Η κυριότερη αιτία της ραγδαίας αύξησης του επιπολασμού της νεφρικής νόσου την τελευταία εικοσαετία είναι η αύξηση του επιπολασμού του Σακχαρώδη Διαβήτη Τύπου 2 (ΣΔΤ2), της συχνότερης αιτίας της νεφροπάθειας. Στους ασθενείς με διαβητική νεφροπάθεια (ΔΝ), ακόμα και στα αρχικά στάδια, παρατηρείται επιταχυνόμενη επασβέστωση των αγγείων και συνεπώς η καρδιαγγειακή νόσος αποτελεί την πρώτη αιτία θνητότητας και νοσηρότητας.Η Matrix Gla Protein (MGP) αποτελεί την πρώτη πρωτεΐνη που αναγνωρίστηκε in vitro και in vivo ως ισχυρός αναστολέας αγγειακής επασβέστωσης (ΑΕ). Πρόκειται για μία βιταμινο-Κ εξαρτώμενη πρωτεΐνη 84 αμινοξέων, μοριακού βάρους 12 kDa, που εκφράζεται από τα χονδροκύτταρα και τα λεία μυϊκά κύτταρα του αγγειακού τοιχώματος. Για να γίνει βιολογικά δραστική η MGP πρέπει να υποστεί γ-καρβοξυλίωση και φωσφορυλίωση, διαδικασίες που εξαρτώνται από τις διαθέσιμη ποσότητα βιταμίνης Κ. Η ανενεργός, μη-καρβοξυλιωμένη, μη-φωσφορυλιωμένη μορφή της MGP (dpucMGP) έχει σχετιστεί επανειλημμένως με ανάπτυξη ΑΕ, αλλά και με εξέλιξη της ΧΝΝ.Αρκετές μελέτες έχουν δείξει πως εκτός από διαιτητικούς, εμπλέκονται και γενετικοί παράγοντες στον κύκλο της βιταμίνης Κ (ανακύκλωση της βιταμίνης Κ) και μπορούν να οδηγήσουν σε μειωμένη δραστικότητα της MGP και συνεπώς σε ΑΕ. Η υπομονάδα 1 του συμπλόκου της αναγωγάσης του εποξειδίου της βιταμίνης Κ (Vitamin K Epoxide Reductase Complex Subunit 1 – VKORC1) είναι βασικό συστατικό του κύκλου της βιταμίνης Κ, καθώς είναι το υπεύθυνο ένζυμο για την ολοκλήρωση της μετατροπής του εποξειδίου της βιταμίνης Κ σε βιταμίνη Κ και συνεπώς, της ανακύκλωσής της. Μονονουκλεοτιδικοί γονιδιακοί πολυμορφισμοί (single nucleotide polymorphisms, SNPs) στο γονίδιο που κωδικοποιεί το υπεύθυνο ένζυμο για την ανακύκλωση της βιταμίνης Κ έχουν συσχετιστεί με επιταχυνόμενη ΑΕ της αορτής. Στην περιοχή του υποκινητή του γονιδίου VKORC1 έχει ταυτοποιηθεί ο πολυμορφισμός -1639G>A. Φορείς του G αλληλομόρφου εμφανίζουν αυξημένη κατά 44% δραστικότητα του υποκινητή και αυξημένα επίπεδα ενζύμου VKORC1. Ένας άλλος παράγοντας που επηρεάζει τα επίπεδα της βιταμίνης Κ είναι η απολιποπρωτεϊνη Ε (apoE) η οποία διευκολύνει την κυτταρική πρόσληψη των χυλομικρών που αποτελούν το φορέα μεταφοράς της βιταμίνης Κ στο αίμα. Τα τρία συνηθισμένα αλληλόμορφα της apoE διαφέρουν στην ικανότητά τους να διευκολύνουν την κάθαρση των πλούσιων σε βιταμίνη Κ λιποπρωτεϊνών από την κυκλοφορία με αποτέλεσμα τα επίπεδα πλάσματος της βιταμίνης Κ να μεταβάλλονται στους φορείς των τριών αλληλομόρφων της apoE. Το γονίδιο που κωδικοποιεί την MGP έχει οκτώ SNPs στον υποκινητή και στις περιοχές κωδικοποίησης. O πολυμορφισμός T-138C (rs 1800802) βρίσκεται σε περιοχή του υποκινητή που είναι απαραίτητος για τη μεταγραφή στα λεία μυϊκά κύτταρα των αγγείων. Αρκετοί ερευνητές έχουν δείξει πως η κυκλοφορούσα dpucMGP είναι ανεξάρτητος παράγοντας κινδύνου για ολική και ΚΑ θνητότητα σε διάφορους πληθυσμούς.Στην παρούσα μελέτη, σε διαβητικούς ασθενείς με ΔΝ και σε διαβητικούς χωρίς ΔΝ, μετρήθηκαν τα επίπεδα της κυκλοφορούσας dpucMGP, το πάχος του Ε-ΜΧΚ -ως υποκλινικού δείκτη αθηροσκλήρωσης-, και εκτιμήθηκε η επίδραση γενετικών πολυμορφισμών των γονιδίων των MGP, VKORC1 και apoE σε σχέση με το πάχος του Ε-ΜΧΚ και τα επίπεδα της dpucMGP. Επίσης αξιολογήθηκε η επίδραση των παραπάνω παραγόντων στην ολική και ΚΑ θνητότητα, τα ΚΑ επεισόδια και την εξέλιξη της νεφρικής νόσου στον πληθυσμό αυτό.Η γονοτύπηση των πολυμορφισμών του VKORC1-1639G>A, της MGP -138 T>C και της apoE πραγματοποιήθηκε με τη μέθοδο PCR-RFLP (polymerase chain reaction-restriction fragment length polymorphism) σε 40 ασθενείς με ΣΔΤ2 και φυσιολογική νεφρική λειτουργία (ομάδα ελέγχου) και 118 ασθενείς με διάφορα στάδια διαβητικής ΧΝΝ (1-5, συμπεριλαμβανομένων ασθενών υπό αιμοκάθαρση με τεχνητό νεφρό- ΤΝ). Τα επίπεδα της dp-ucMGP του πλάσματος υπολογίστηκαν με τη μέθοδο ELISA (enzyme-linked immunosorbent assay). Σε όλους τους ασθενείς της μελέτης μετρήθηκε υπερηχογραφικά το πάχος του έσω-μέσου χιτώνα της κοινής καρωτίδας αρτηρίας (Ε-ΜΧΚ), με υψηλής ευκρίνειας υπερηχογραφικό μηχάνημα Doppler. Ο πληθυσμός της μελέτης παρακολουθήθηκε για μια 7ετία, με καταληκτικά σημεία την ολική θνητότητα, την ΚΑ θνητότητα και τα ΚΑ συμβάντα (θανατηφόρα και μη).Τα επίπεδα πλάσματος dpucMGP και η τιμή του πάχους Ε-ΜΧΚ σχετίστηκαν στατιστικά σημαντικά με την εξέλιξη της ΔΝ (P<0,0001 και P=0,004 αντιστοίχως). Η συγκέντρωση της dpucMGP ορού δε σχετίστηκε με κανέναν από τους τρεις πολυμορφισμούς ή το πάχος E-MXK. Ενώ οι πολυμορφισμοί VKORC1 -1639G > A και apoE δε σχετίστηκαν, ο πολυμορφισμός MGP T-138C σχετίστηκε με το πάχος του Ε-ΜΧΚ. Οι TT ομοζυγώτες εμφάνιζαν υψηλότερες πάχους Ε-ΜΧΚ συγκριτικά με τους γονότυπους TC και CC μαζί (P=0,006). Ο MGP T-138C ήταν ανεξάρτητος προγνωστικός παράγοντας του πάχους Ε-ΜΧΚ, μετά από προσαρμογή για αρκετούς παράγοντες κινδύνου για ΑΕ (P<0,0001). Επιπλέον, οι ομοζυγώτες ΤΤ εμφάνισαν μεγαλύτερη συχνότητα στην ομάδα των ασθενών υπό ΤΝ σε σύγκριση με την ομάδα της ΧΝΝ σταδίων 1-4 (P= 0,002). Κατόπιν προσαρμογής για αρκετούς παράγοντες κινδύνου, η πολυπαραγοντική ανάλυση Cox έδειξε πως οι ασθενείς με τον γονότυπο TT είχαν σχεδόν 5-πλάσιο κίνδυνο για ολική θνητότητα (Hazard Ratio -HR 4,67, 95% Confidence Interval -CI 1,37-15,94, P=0,01) και ΚΑ θνητότητα (HR 5,07, 95% CI 1,07-24,09, P=0,04) σε σχέση με τους ασθενείς που είχαν τους γονότυπους TC/CC. Στην υπο-ομάδα των ασθενών που μετρήθηκε η dpucMGP, η πολυπαραγοντική ανάλυση Cox έδειξε πως η υψηλή dpucMGP πλάσματος> 646 pM είναι ανεξάρτητος παράγοντας κινδύνου για ολική θνητότητα – [HR 2,97, 95% CI 1,27-6,95, P=0,012], KA θνητότητα - (HR 5,49, 95% CI 1,85-16,33, P=0,002) και εμφάνιση ΚΑ συμβάματος- (HR 2,07 95% CI 1,00-4,20, P=0,047) συγκριτικά με τους ασθενείς στην ομάδα της χαμηλής dpucMGP.Καθώς η MGP αποτελεί σημαντικό αναστολέα της ιστικής και αγγειακής επασβέστωσης, η μελέτη μας υποδεικνύει ότι μάλλον υπάρχει γενετική βάση στην επασβέστωση των ασθενών με διαβητική νεφροπάθεια. Θα μπορούσαμε να υποθέσουμε ότι ο πολυμορφισμός T-138C της MGP ίσως προδιαθέτει γενετικά στην έκφραση της αγγειακής επασβέστωσης.

scholarly journals Inhibiting SLC26A4 reverses cardiac hypertrophy in H9C2 cells and in rats

PeerJ ◽  
2020 ◽  
Vol 8 ◽  
pp. e8253
Author(s):  
Liqun Tang ◽  
Xiaoqin Yu ◽  
Yangyang Zheng ◽  
Ning Zhou
Keyword(s):  
Cardiac Hypertrophy ◽  
Natriuretic Peptide ◽  
Quantitative Polymerase Chain Reaction ◽  
Pendred Syndrome ◽  
Abdominal Aortic ◽  
Polymerase Chain ◽  
Gsk 3Β

Background It has been confirmed that mutations in solute carrier family 26 member 4 (SLC26A4) contribute to pendred syndrome. However, the role of SLC26A4 in cardiac hypertrophy and the signaling pathways remain unclear. Methods Cardiomyocytes were treated by 200 µM phenylephrine (PE) to induce cardiac hypertrophy. Also, the expression of SLC26A4, GSK3, cardiac hypertrophy markers including atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) was detected through real-time quantitative polymerase chain reaction (RT-qPCR). Flow cytometry assay was used to test the apoptosis of PE-induced cardiomyocytes transfected by small interfere RNA (siRNA)-SLC26A4. Furthermore, we detected the expression of autophagy-related markers including light chain 3 (LC3) and P62. Finally, we established a rat model of abdominal aortic constriction (AAC)-induced cardiac hypertrophy in vivo. Results RT-qPCR results showed that the mRNA expression of SLC26A4 was significantly up-regulated in PE-induced cardiac hypertrophy. After inhibiting SLC26A4, the release of ANP and BNP was significantly decreased and GSK3β was elevated in vivo and in vitro. Furthermore, inhibiting SLC26A4 promoted apoptosis of cardiac hypertrophy cells. In addition, LC3 was down-regulated and P62 was enhanced after transfection of siRNA-SLC26A4. Conclusion Our findings revealed that SLC26A4 increases cardiac hypertrophy, and inhibiting SLC26A4 could decrease the release of ANP/BNP and promote the expression of GSK-3β in vitro and in vivo. Moreover, SLC26A4 silencing inhibits autophagy of cardiomyocytes and induces apoptosis of cardiomyocytes. Therefore, SLC26A4 possesses potential value to be a therapeutic target of cardiac hypertrophy, and our study provides new insights into the mechanisms of cardiac hypertrophy.

scholarly journals An In Vitro Verification of the Effects of Paeoniflorin on Lipopolysaccharide-Exposed Microglia

2020 ◽  
Vol 2020 ◽  
pp. 1-10
Author(s):  
Qiliang Chen ◽  
Yaojun Liu ◽  
Yuanyuan Zhang ◽  
Xinyu Jiang ◽  
Yuqin Zhang ◽  
...  
Keyword(s):  
Signaling Pathway ◽  
Nuclear Factor Kappa B ◽  
Brain Injuries ◽  
Enzyme Linked Immunosorbent Assay ◽  
Neuroprotective Effects ◽  
Polymerase Chain ◽  
New Treatment ◽  
Culture Supernatants

Background. The neuroprotective effects of Paeoniflorin (PF) are well known. Most of the evidence was verified in vivo. We attempted to perform an in vitro verification of the effects of PF in microglia. Methods. A lipopolysaccharide- (LPS-) exposed microglia model was employed. An enzyme-linked immunosorbent assay was used to measure the levels of cytokines in the culture supernatants. A real-time polymerase chain reaction was performed to measure the mRNA expression of cytokines and M1- and M2-like genes. A western blot analysis was used to examine the expression of proteins associated with the nuclear factor-kappa B (NF-κB) signaling pathway. Results. We found that the administration of PF reversed the inflammatory response induced by LPS. It downregulated proinflammatory cytokines and upregulated anti-inflammatory cytokines. This, in turn, alleviated the oxidative injuries, downregulated the expression of M1-like genes, and upregulated the expression of M2-like genes. PF can also reverse the changes in proteins associated with the NF-κB signaling pathway induced by LPS. Conclusions. We provided evidence obtained in vitro concerning the neuroprotective effects of PF via suppressing activation of microglia, which might be associated with the NF-κB signaling pathway. These findings contribute to obtaining a deeper understanding of PF, a potential new treatment for brain injuries.

Sign in / Sign up

Export Citation Format

Share Document